Jvion delivers data-driven insights to NTT DATA clients to identify unforeseen risks, assess modifiable patients & improve health outcomes
Atlanta, GA – March 16, 2022 – Jvion, a leader in AI-enabled prescriptive analytics, announced today an agreement with NTT DATA, a global leader in business and IT solutions. Jvion’s flagship clinical intelligence solution, the Jvion CORE™, will integrate into NTT DATA’s Nucleus for Healthcare platform. The integration will allow users to more readily identify and assess risks, evaluate modifiable patients, and adjust patients’ health trajectories toward improved outcomes.
“We’re thrilled to introduce Jvion’s clinical AI capabilities to the Nucleus for Healthcare platform,” said Curt Thornton, Chief Growth Officer at Jvion. “As part of NTT DATA’s streamlined ecosystem, Jvion will be able to empower even more healthcare professionals with the kinds of cutting-edge, clinical insights they need in order to deliver efficient, personalized care that puts the patient experience first. As we continue on our mission to improve care and avoid harm, I have no doubt that Jvion will be right at home on the Nucleus platform.”
Nucleus for Healthcare is an integrated digital health accelerator that streamlines clinical engagements and unifies patient experience through personalized communication, consolidated clinical and financial data, and predictive analytics. Jvion’s prescriptive intelligence solution, the Jvion CORE™, combines clinical, socioeconomic, environmental and behavioral data and applies sophisticated algorithms to:
- Identify Unforeseen Risk, by finding hidden patient and financial risks for everything from avoidable admissions to individual social vulnerabilities
- Assess Modifiable Patients, by pinpointing the individuals whose risk trajectory can be altered
- Intervene, by changing outcomes through evidence-based recommendations and patient-specific interventions and integrating them into existing workflows
“Jvion is an excellent addition to our Nucleus for Healthcare platform,” said Lisa Esch, Chief of Strategy, Innovation and Provider Industry Solutions, NTT DATA Services. “Their prescriptive intelligence offering goes beyond simple risk stratification, and instead ties risk to action, helping to create the actionable insights clients need to reduce costs, improve care, and change patient outcomes for the better.”
To learn more about Jvion and its prescriptive intelligence solutions, visit www.jvion.com.
Jvion, a leader in AI-enabled prescriptive intelligence, enables providers, payers, and other healthcare entities to identify and prevent avoidable patient harm, utilization, and costs. An industry first, the Jvion CORE™ goes beyond predictive analytics and machine learning to identify patients on a trajectory to becoming high-risk. Jvion then determines the interventions that will more effectively reduce risk and enable clinical and operational action. The CORE accelerates time to value by leveraging established patient-level intelligence to drive engagement across healthcare organizations, populations, and individuals. To date, the Jvion CORE has been deployed across hundreds of clients and resulted in millions saved. For more information, visit https://www.jvion.com
About NTT DATA
NTT DATA – a part of NTT Group – is a trusted global innovator of IT and business services headquartered in Tokyo. We help clients transform through consulting, industry solutions, business process services, digital & IT modernization and managed services. NTT DATA enables them, as well as society, to move confidently into the digital future. We are committed to our clients’ long-term success and combine global reach with local client attention to serve them in over 50 countries around the globe. Visit us at nttdata.com.